MedPath

' Biomarkers for minimal residual disease in neuro-oncology ': MIRDINO study

Withdrawn
Conditions
braintumors
10029211
Registration Number
NL-OMON46208
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
400
Inclusion Criteria

- Radiologicaland if possible histological proven diagnosis of any CNS tumor (M0-M4)
- Any age group
- Written informed consent obtained of the patients and/or their parents or legal guardians

Exclusion Criteria

see inclusion criteria

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath